Discovery of New Catalytic Topoisomerase II Inhibitors for Anticancer Therapeutics

Poison inhibitors of DNA topoisomerase II (TOP2) are clinically used drugs that cause cancer cell death by inducing DNA damage, which mechanism of action is also associated with serious side effects such as secondary malignancy and cardiotoxicity. In contrast, TOP2 catalytic inhibitors induce limite...

Descripción completa

Detalles Bibliográficos
Autores principales: Matias-Barrios, Victor M., Radaeva, Mariia, Song, Yi, Alperstein, Zaccary, Lee, Ahn R., Schmitt, Veronika, Lee, Joseph, Ban, Fuqiang, Xie, Ning, Qi, Jianfei, Lallous, Nada, Gleave, Martin E., Cherkasov, Artem, Dong, Xuesen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883873/
https://www.ncbi.nlm.nih.gov/pubmed/33598437
http://dx.doi.org/10.3389/fonc.2020.633142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883873/
https://www.ncbi.nlm.nih.gov/pubmed/33598437
http://dx.doi.org/10.3389/fonc.2020.633142

Ejemplares similares